GSM821578 |
Peripheral blood mononuclear cells of 205-Cy5 post-treatment and 131-Cy3 pre-treatment dasatinib non-responder patient |
GSM821579 |
Peripheral blood mononuclear cells of 195-Cy3 post-treatment and 148-Cy5 pre-treatment dasatinib non-responder patient |
GSM821580 |
Peripheral blood mononuclear cells of 195-Cy5 post-treatment and 148-Cy3 pre-treatment dasatinib non-responder patient |
GSM821581 |
Peripheral blood mononuclear cells of 235-Cy3 post-treatment and 155-Cy5 pre-treatment dasatinib non-responder patient |
GSM821582 |
Peripheral blood mononuclear cells of 235-Cy5 post-treatment and 155-Cy3 pre-treatment dasatinib non-responder patient |
GSM821583 |
Peripheral blood mononuclear cells of 221-Cy3 post-treatment and 136-Cy5 pre-treatment dasatinib responder patient |
GSM821584 |
Peripheral blood mononuclear cells of 221-Cy5 post-treatment and 136-Cy3 pre-treatment dasatinib responder patient |
GSM821585 |
Peripheral blood mononuclear cells of 240-Cy3 post-treatment and 150-Cy5 pre-treatment dasatinib responder patient |
GSM821587 |
Peripheral blood mononuclear cells of 240-Cy5 post-treatment and 150-Cy3 pre-treatment dasatinib responder patient |
GSM821592 |
Peripheral blood mononuclear cells of 234-Cy3 post-treatment and 152-Cy5 pre-treatment dasatinib responder patient |
GSM821854 |
Peripheral blood mononuclear cells of 234-Cy5 post-treatment and 152-Cy3 pre-treatment dasatinib responder patient |
GSM821861 |
Peripheral blood mononuclear cells of 128-Cy3 pre-treatment and 239-Cy5 post-treatment dasatinib non-responder patient |
GSM821871 |
Peripheral blood mononuclear cells of 128-Cy5 pre-treatment and 239-Cy3 post-treatment dasatinib non-responder patient |
GSM821906 |
Peripheral blood mononuclear cells of 131-Cy3 pre-treatment and 205-Cy5 post-treatment dasatinib non-responder patient |
GSM821986 |
Peripheral blood mononuclear cells of 131-Cy5 pre-treatment and 205-Cy3 post-treatment dasatinib non-responder patient |
GSM822130 |
Peripheral blood mononuclear cells of 148-Cy3 pre-treatment and 195-Cy5 post-treatment dasatinib non-responder patient |
GSM822200 |
Peripheral blood mononuclear cells of 148-Cy5 pre-treatment and 195-Cy3 post-treatment dasatinib non-responder patient |
GSM822210 |
Peripheral blood mononuclear cells of 155-Cy3 pre-treatment and 235-Cy5 post-treatment dasatinib non-responder patient |
GSM822239 |
Peripheral blood mononuclear cells of 155-Cy5 pre-treatment and 235-Cy3 post-treatment dasatinib non-responder patient |
GSM822240 |
Peripheral blood mononuclear cells of 136-Cy3 pre-treatment and 221-Cy5 post-treatment dasatinib responder patient |
GSM822241 |
Peripheral blood mononuclear cells of 136-Cy5 pre-treatment and 221-Cy3 post-treatment dasatinib responder patient |
GSM822266 |
Peripheral blood mononuclear cells of 150-Cy3 pre-treatment and 240-Cy5 post-treatment dasatinib responder patient |
GSM822315 |
Peripheral blood mononuclear cells of 150-Cy5 pre-treatment and 240-Cy3 post-treatment dasatinib responder patient |
GSM822324 |
Peripheral blood mononuclear cells of 152-Cy3 pre-treatment and 234-Cy5 post-treatment dasatinib responder patient |
GSM822401 |
Peripheral blood mononuclear cells of 152-Cy5 pre-treatment and 234-Cy3 post-treatment dasatinib responder patient |